MADONA: Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
Study Details
Study Description
Brief Summary
The purpose of this study is to assess the impact of three different treatment modalities on panic symptoms, quality of life and use of health services among individuals consulting an emergency department for non cardiac chest pain and having Panic Disorder.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: 1
|
Behavioral: Brief cognitive-behavioral treatment for Panic Disorder
One two-hour session of cognitive-behavior therapy for panic disorder
|
Active Comparator: 2
|
Behavioral: Cognitive-Behavior Therapy for Panic Disorder
Seven one-hour sessions of cognitive-behavior therapy for panic disorder
|
Active Comparator: 3
|
Drug: paroxetine
40 mg die, for 6 months
|
No Intervention: 4
|
Outcome Measures
Primary Outcome Measures
- Panic Disorder diagnosis [Pre and posttreatment, and 3, 6 and 12 months after treament]
Secondary Outcome Measures
- Panic symptomatology, psychological distress, quality of life, and use of health services [Pre and posttreatment, and 3, 6 and 12 months after treatment]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Aged 18 and over
-
Mastered oral and written French
-
Consulted an emergency department for chest pain with very low risk of coronary disease (normal ECG and blood tests)
-
Met criteria for Panic Disorder
Exclusion Criteria:
-
Chest pain with an obvious medical origin (obvious trauma or abnormal pulmonary x-rays)
-
Had received cognitive-behavior therapy for Panic Disorder in the last six months
-
Cognitive impairment preventing the completion of psychological assessment
-
Past or present psychotic episode, Bipolar Disorder, or organic mental disorder
-
Current Abuse or Dependence Disorder
-
If another Mental Disorder is present, its severity was equal or inferior to the severity of Panic Disorder
-
Current medical condition preventing the participant from receiving pharmacological of cognitive-behavior treatment
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hôtel-Dieu de Lévis | Lévis | Quebec | Canada | G6V 3Z1 |
2 | Institut de Cardiologie de Montréal (Montreal Heart Institute) | Montréal | Quebec | Canada | H1T 1C8 |
3 | Hôpital du Sacré-Coeur de Montréal | Montréal | Quebec | Canada | H4J 1C5 |
Sponsors and Collaborators
- Université du Québec a Montréal
- Canadian Institutes of Health Research (CIHR)
Investigators
- Principal Investigator: André Marchand, PhD, Université du Québec a Montréal
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- MOP 81128 (CIHR)